Rhaeos

wearables for chronic conditions 🩹 leading with hydrocephalus 🧠 FDA breakthrough designated 💡

[Rhaeos @rhaeos]

🚨Attn #Boston nurses🚨in neurosurgery! We are conducting paid studies regarding a novel #hydrocephalus device on-site at the Boston convention center TODAY, 4/27. Compensation is $250 for 45 min. Email [email protected] if interested! #AANS2025 #nurse #neurosurgery #AANS

[Rhaeos @rhaeos]

There are still slots available for a paid study on the exhibit floor of #AANS2025. In search of #nurses and #neurosurgeons!! $250 for 45 min

[Rhaeos @rhaeos]

🚨Attention 🚨surgeons and nurses in #neurosurgery attending the #AANS conference! We are conducting paid studies regarding a novel #hydrocephalus device on-site at the conference. Email [email protected] if interested! #AANS2025

[Rhaeos @rhaeos]

🚨Attention 🚨surgeons and nurses in #neurosurgery attending the #AANS conference! We are conducting paid studies regarding a novel #hydrocephalus device on-site at the conference. Email [email protected] if interested! #AANS2025

[Rhaeos @rhaeos]

Experience non-invasive, wireless monitoring of your #hydrocephalus #shunt! Email [email protected] to learn more about our paid studies in Tampa in a few weeks!! @hydroassoc #HAConnect #spinabifida

[Rhaeos @rhaeos]

Experience non-invasive, wireless monitoring of your shunt at #HAConnect. Email [email protected] to learn more about our paid studies in Tampa in a few weeks!! #hydrocephalus #spinabifida #csf @HydroAssoc

[Rhaeos @rhaeos]

We are excited to sponsor the @hydroassoc National Conference on #Hydrocephalus, #HACONNECT, held July 25-27 in Tampa! @rhaeos will also be conducting PAID clinical studies onsite for those with #shunts! Experience completely non-invasive, wireless monitoring of CSF flow. Contact [email protected] for more info!!

[Rhaeos @rhaeos]

Join the #FlowSense revolution by Rhaeos! People with a #shunt that no longer works (broken or disconnected) or is turned off (ligated, tied-off, or valve set to ‘virtual off’) as well as people with a working shunt may be included in this study. Help us bring non-invasive #hydrocephalus care to all. Paid Opportunity | 1-1.5 hrs | Contact [email protected] for more information!

[Rhaeos @rhaeos]

$100 paid research study in Houston for people with #hydrocephalus for 1.5hrs of your time using our non-invasive device to detect shunt flow. Email [email protected] for details!! $25 referral bonuses too! #spinabifida #neurosurgery #shunts

[Rhaeos @rhaeos]

🚨Hey #Houston! We’re coming!🚨 @rhaeos will be in town from 4/25-4/27 for our PAID #hydrocephalus clinical study. Ubers or parking will also be covered. It’s a single visit for 1-2 hours. No devices will be taken home. Device is completely non-invasive. If interested email [email protected] for more details. #shunts #spinabifida #csf #neurosurgery

[Rhaeos @rhaeos]

🚨Hey #SoCal! 🚨 @rhaeos will be in #Orangecounty and #LosAngeles from 4/18-4/20 for our PAID #hydrocephalus clinical study at CHOC and Cedars-Sinai Accelerator. Ubers or parking will also be covered. It’s a single visit for 1-2 hours. Device is completely non-invasive. If interested email [email protected] for more details. #shunts #spinabifida #csf #neurosurgery

[Rhaeos @rhaeos]

@rhaeos is conducting a PAID clinical study of #FlowSense in downtown Chicago and Rolling Meadows! Travel or parking compensated. Open to out of state participants! Email [email protected] for more information! Limited slots available. #hydrocehalus #shunts #spinabifida

[Rhaeos @rhaeos]

🚨Attention 🚨 #hydrocephalus community! @rhaeos is conducting a PAID clinical study of #FlowSense in downtown Chicago and Rolling Meadows! Travel or parking compensated. Open to out of state participants! Email [email protected] for more information! Limited slots available.

[Rhaeos @rhaeos]

🚨Attention 🚨 #hydrocephalus community! @rhaeos is conducting a PAID clinical study of #FlowSense in downtown Chicago and Rolling Meadows! Travel or parking compensated. Open to out of state participants! Email [email protected] for more information! Limited slots available.

[Rhaeos @rhaeos]

🐼 @Rhaeos has joined forces with Panda Express to support Hydrocephalus Association! 🐼 Order up some delicious eats like orange chicken, kung pao chicken, chow mein, and fried rice, and help make a difference. Share your order, tag @HydroAssoc, and spread the word! #whoshungry #hydrocephalus #hydrocephalusawareness #neurosurgery #pandaexpressday #HydroAssocXPANDAEXPRESS #employeelunch

[Rhaeos @rhaeos]

Come visit @rhaeos at the Southern Neurosurgical Society’s annual meeting in Orlando this week to learn more about our #hydrocephalus diagnostic solutions. #neurosurgery #shunts @southernneuro

[John A Rogers @ProfJohnARogers]

Looking forward to delivering the Grand Rounds lecture tomorrow to @NUFeinbergMed. The lecture content will include a range of innovative hardware solutions to challenging, unmet needs.  From the world’s smallest pacemakers, to wireless vital signs monitoring systems for maternal, fetal and neonatal health, to implants for monitoring transplant rejection, to resorbable wireless diaphragm stimulators, to flow sensors for shunted hydrocephalus patients and much more! Additional information could be found here: https://t.co/BSo6VIohjN.

[Rhaeos @rhaeos]

2023 was a banner year for Team Rhaeos where we kicked off the first quarter with a Series A close and closed the last quarter with the completion of our 9 center FDA pivotal study. Here are some highlights of the year:

💰Series A close of $10.5M ✅. The round was led by the Steele Foundarion for Hope with follow on investments from Creative Ventures and Lateral Capital.

💰Non-dilutive funding ✅ We received a BP MedTech and diversity grants from the NIH. We also received funding from the Southwest Pediatric Device Consortium and the West Coast Consortium for Technology and Innovations. Funds total >$1.6M.

🏥 FDA pivotal study ✅. We completed a 9 center study in the US - coast to coast from UCSF to Duke. We are thankful for our collaborators across the country!

🔬FlowSense home device study cohort #1 ✅. We kicked off our clinical study to bring our remote wearable home!

🏥 5 Clinical studies ✅. CLINICAL EVIDENCE MATTERS! Rhaeos completed 5 clinical studies this year, adding significant data to our portfolio of products.

🥼Chief Medical Officer ✅. Internationally renowned hydrocephalus researcher and neurosurgeon, Dave Limbrick, Jr. MD, PhD joined us as our CMO!

🌎Conferences ✅. We exhibited at major national and international neurosurgery, hydrocephalus, and digital health conferences including CNS, AANS, Hydrocephalus 2023, HLTH, and more!

🧍‍♀️🧍‍♂️Team Expansion ✅. We added 13 employees and consultants to the team.

🇬🇧 International Accelerator ✅. We were selected to participate in the Cedars-Sinai/NHS/KHP Ventures Accelerator in London.

What’s in store for 2024? A LOT. Keep following us for more.

[Rhaeos @rhaeos]

Amidst our startup hustle, @Rhaeos had our annual service project at the @FoodDepository - packing fruit for the less fortunate. To cap off a fantastic year, we went to #Chinatown for #dimsum at MingHin! Happy holidays, everyone! ⛄️ #impact #neurosurgery #hydrocephalus

[Rhaeos @rhaeos]

Wishing you joy, warmth, and moments of magic this holiday season! ☃️ We are thankful to all of our partners and supporters for an incredible 2023. Here’s to a year of impact and solutions for the #hydrocephalus community! 2024 will be even better! #neurosurgery